POLR2C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.586400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.041970E-01
Normal-vs-Stage2
2.760200E-01
Normal-vs-Stage3
8.637400E-01
Normal-vs-Stage4
1.715020E-01
Stage1-vs-Stage2
6.887000E-01
Stage1-vs-Stage3
3.353600E-01
Stage1-vs-Stage4
3.231000E-01
Stage2-vs-Stage3
3.482000E-01
Stage2-vs-Stage4
2.686400E-01
Stage3-vs-Stage4
1.780400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.572800E-01
Normal-vs-AfricanAmerican
1.637620E-01
Normal-vs-Asian
6.764400E-01
Caucasian-vs-AfricanAmerican
2.467800E-01
Caucasian-vs-Asian
1.764990E-01
AfricanAmerican-vs-Asian
9.795600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.668600E-01
Normal-vs-Female
2.485600E-01
Male-vs-Female
4.514000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.810200E-01
Normal-vs-Age(41-60Yrs)
3.134100E-02
Normal-vs-Age(61-80Yrs)
4.107000E-01
Normal-vs-Age(81-100Yrs)
3.837600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.493200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.609800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.630800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.106310E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.158000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.648200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.831800E-01
Normal-vs-Daily Drinker
5.445600E-01
Normal-vs-Weekly Drinker
6.604600E-01
Normal-vs-Occasional Drinker
4.400300E-02
Normal-vs-Social Drinker
1.375040E-01
Non Drinker-vs-Daily Drinker
8.001800E-01
Non Drinker-vs-Weekly Drinker
7.010200E-01
Non Drinker-vs-Occasional Drinker
7.222700E-03
Non Drinker-vs-Social Drinker
9.195900E-02
Daily Drinker-vs-Weekly Drinker
6.273200E-01
Daily Drinker-vs-Occasional Drinker
6.033900E-02
Daily Drinker-vs-Social Drinker
2.724400E-01
Weekly Drinker-vs-Occasional Drinker
1.242050E-02
Weekly Drinker-vs-Social Drinker
9.237700E-02
Occasional Drinker-vs-Social Drinker
4.287600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.632560E-01
Normal-vs-Grade 2
5.901600E-01
Normal-vs-Grade 3
5.497200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.710400E-01
Grade 1-vs-Grade 3
4.695200E-01
Grade 1-vs-Grade 4
1.632560E-01
Grade 2-vs-Grade 3
2.601800E-01
Grade 2-vs-Grade 4
5.901600E-01
Grade 3-vs-Grade 4
5.497200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.093000E-01
Normal-vs-NonDiabetic
2.290400E-01
Diabetic-vs-NonDiabetic
6.007800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.207400E-01
Normal-vs-NoPancreatitis
2.944600E-01
Pancreatitis-vs-NoPancreatitis
6.983200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.953390E-01
Normal-vs-N1
2.951000E-01
N0-vs-N1
1.072390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.548200E-02
Normal-vs-TP53-NonMutant
2.942000E-01
TP53-Mutant-vs-TP53-NonMutant
2.211900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
